Skip to content

Derivative assets at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$71.4M-7.5%
Gross profit$21.2M-11.6%
Operating income$5.2M-38.6%
Net income$3.4M-30.1%
EPS (diluted)$1.13-30.7%

Balance sheet

See full
Cash & equivalents$10.0M-42.0%
Total debt$25.3M+6.6%
Total equity$74.7M+15.9%
Total assets$178.3M-8.4%

Cash flow

See full
Operating cash flow$5.5M-42.0%
CapEx$928.0K+79.8%
Free cash flow$4.5M-49.0%

Valuation

See full
Market cap$101.96M-32.7%
Enterprise value$117.3M-26.0%
P/E10.6×-2.7×
P/S0.4×-0.3×

Profitability

See full
Gross margin28.5%-0.1pp
Operating margin5.9%-1.5pp
Net margin3.4%-1.3pp
FCF margin5.2%

Returns & leverage

See full
Return on equity13.8%-5.3pp
Debt / equity0.3×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by Kewaunee Scientific Corporation in its filing.

Tagged under the XBRL concept us-gaap:DerivativeAssets.

The official record: Kewaunee Scientific Corporation’s 10-Q, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kewaunee Scientific Corporation's derivative assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kewaunee Scientific Corporation's derivative assets?
Kewaunee Scientific Corporation (KEQU) reported derivative assets of $4.07M in Q4 2025.
How has Kewaunee Scientific Corporation's derivative assets changed year-over-year?
Kewaunee Scientific Corporation's derivative assets increased by 22.1% year-over-year, from $3.33M to $4.07M.
What is the long-term trend for Kewaunee Scientific Corporation's derivative assets?
Over 4 years (2021 to 2025), Kewaunee Scientific Corporation's derivative assets has grown at a 4.3% compound annual growth rate (CAGR), from $2.76M to $3.26M.
What does derivative assets mean?
Fair value of derivative contracts (swaps, options, forwards, futures) in a net gain position — represents amounts owed to the firm by counterparties.